179 related articles for article (PubMed ID: 1335685)
1. Retinoids--"differentiation agents" for cancer treatment and prevention.
Hofmann SL
Am J Med Sci; 1992 Sep; 304(3):202-13. PubMed ID: 1335685
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
5. Retinoids in cancer chemoprevention.
Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
[TBL] [Abstract][Full Text] [Related]
6. Retinoids in chemoprevention and differentiation therapy.
Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Miyauchi J; Ohyashiki K; Inatomi Y; Toyama K
Blood; 1997 Jul; 90(2):803-13. PubMed ID: 9226181
[TBL] [Abstract][Full Text] [Related]
8. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
9. Retinoids and differentiation treatment: a strategy for treatment in cancer.
Cornic M; Agadir A; Degos L; Chomienne C
Anticancer Res; 1994; 14(6A):2339-46. PubMed ID: 7825969
[TBL] [Abstract][Full Text] [Related]
10. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
11. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid.
Kitamura K; Hoshi S; Koike M; Kiyoi H; Saito H; Naoe T
Br J Haematol; 2000 Mar; 108(4):696-702. PubMed ID: 10792271
[TBL] [Abstract][Full Text] [Related]
13. Retinoid differentiation therapy in promyelocytic leukemia.
Chomienne C; Fenaux P; Degos L
FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
[TBL] [Abstract][Full Text] [Related]
14. [Retinoids and acute promyelocytic leukemia].
Hashimoto Y; Shudo K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2203-9. PubMed ID: 1656889
[TBL] [Abstract][Full Text] [Related]
15. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
16. The success and the challenge of all-trans retinoic acid in the treatment of cancer.
Ni X; Hu G; Cai X
Crit Rev Food Sci Nutr; 2019; 59(sup1):S71-S80. PubMed ID: 30277803
[TBL] [Abstract][Full Text] [Related]
17. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.
Pandolfi PP; Grignani F; Alcalay M; Mencarelli A; Biondi A; LoCoco F; Grignani F; Pelicci PG
Oncogene; 1991 Jul; 6(7):1285-92. PubMed ID: 1650447
[TBL] [Abstract][Full Text] [Related]
18. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
20. [New strategy for diagnosis and treatment of acute promyelocytic leukemia with t (15;17)].
Kubo K; Naoe T; Fukutani H; Ohno R
Rinsho Ketsueki; 1994 Mar; 35(3):250-5. PubMed ID: 8158844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
